Skip to main content
FinSpry Logo
FinSpry
AQST logo
AQST
(NASDAQ)
Aquestive Therapeutics, Inc.
$4.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aquestive Therapeutics, Inc. (AQST) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Aquestive Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
(8 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$8.50
↑ 105.81% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AQST Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Roanna Ruiz
Leerink Partners
BuyReiterates
$9.00
James Molloy
Alliance Global Partners
BuyReiterates
$12.00 → $9.00
OpenAI Drug Manufacturers - Specialty and Generic
TipRanks - OpenAI
HoldReiterates
$4.00 → $4.50
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$8.00 → $11.00
James Molloy
Alliance Global Partners
BuyReiterates
$12.00
Francois Brisebois
LifeSci Capital
BuyReiterates
$8.00 → $9.00
Roanna Ruiz
Leerink Partners
BuyMaintains
-
Kristen Kluska
Cantor Fitzgerald
BuyReiterates
$8.00

Frequently Asked Questions

What is the analyst consensus rating for AQST?

The analyst consensus rating for AQST is "Buy" based on 5 analyst recommendations.

What is the average price target for AQST?

The average 12-month price target for AQST is $8.50, representing an upside of 105.8% from the current price of $4.13.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.